PMC:7571312 / 948-1121 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T95582","span":{"begin":45,"end":46},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"inical experiments reveal 4 (PF-00835231) as a potent inhibitor of CoV-2 3CLpro with suitable pharmaceutical properties to warrant further development as an intravenous trea"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":29,"end":31},"obj":"Chemical"},{"id":"T9","span":{"begin":54,"end":63},"obj":"Chemical"},{"id":"T10","span":{"begin":94,"end":108},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_74795"},{"id":"A8","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_90284"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_52217"}],"text":"inical experiments reveal 4 (PF-00835231) as a potent inhibitor of CoV-2 3CLpro with suitable pharmaceutical properties to warrant further development as an intravenous trea"}

{"project":"LitCovid-PubTator","denotations":[{"id":"26","span":{"begin":67,"end":72},"obj":"Species"}],"attributes":[{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"inical experiments reveal 4 (PF-00835231) as a potent inhibitor of CoV-2 3CLpro with suitable pharmaceutical properties to warrant further development as an intravenous trea"}